Labcorp Holdings Community
Create a narrative
WA
Based on Analyst Price Targets
Critical Acquisitions And Innovations Fuel Growth In Medical Genetics And Oncology
US$253.13
FV
12.3% undervalued intrinsic discount5.16%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
about 3 hours agoauthor updated this narrative